Conifer Point Pharmaceuticals
UEI: RFUJM8H9JSU4
• CAGE: 7B5M0
Overview
Awardee Type
Parent
Name
Conifer Point Pharmaceuticals
Website
Headquarters
Doylestown, PA
United States
United States
Most Recent Award
July 1, 2020
Calculating
Conifer Point Pharmaceuticals is a federal grant recipient (UEI RFUJM8H9JSU4; CAGE 7B5M0). It is headquartered in Doylestown, PA. Its primary registered NAICS is 541714: Research and Development in Biotechnology (except Nanobiotechnology). The corporation was founded in December 2014 and federally registered in January 2015.
Federal Award Analysis
Conifer Point Pharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
CONIFER POINT PHARMACEUTICALS LLC
UEI
RFUJM8H9JSU4
CAGE Code
7B5M0
SBA Certifications
None
Self Certifications
For Profit Organization, Limited Liability Company
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Dec. 12, 2014
Initial Registration
Jan. 30, 2015
Last Registration
None
Registration Activation
March 11, 2026
Registration Expiration
March 11, 2027
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
PA
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No